☰

Kathleen C. Torkko, Ph.D. - Publications

Affiliations: 
2005 University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
General, Medicine and Surgery, Oncology, Pathology, Genetics
Tree Info Similar researchers PubMed Report error

45 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Jillson LK, Rider LC, Rodrigues LU, Romero L, Karimpour-Fard A, Nieto C, Gillette C, Torkko K, Danis E, Smith EE, Nolley R, Peehl DM, Lucia MS, Costello JC, Cramer SD. Loss Drives Enhanced Androgen Signaling and Independently Confers Risk of Recurrence in Prostate Cancer with Joint Loss of . Molecular Cancer Research : McR. PMID 33846123 DOI: 10.1158/1541-7786.MCR-20-0913  0.371
2020 Torkko K, Till C, Tangen CM, Goodman PJ, Song X, Schenk JM, Lucia MS, Peters U, van Bokhoven A, Thompson IM, Neuhouser ML. Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial. Cancer Prevention Research (Philadelphia, Pa.). PMID 32102946 DOI: 10.1158/1940-6207.Capr-19-0413  0.438
2019 Panigrahi GK, Praharaj PP, Kittaka H, Mridha AR, Black OM, Singh R, Mercer R, van Bokhoven A, Torkko KC, Agarwal C, Agarwal R, Abd Elmageed ZY, Yadav H, Mishra SK, Deep G. Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patients. Cancer Medicine. PMID 30623593 DOI: 10.1002/Cam4.1885  0.38
2018 Kessler ER, Su LJ, Gao D, Torkko KC, Wacker M, Anduha M, Chronister N, Maroni P, Crawford ED, Flaig TW, Glode LM, Lam ET. Phase II Trial of Acai Juice Product in Biochemically Recurrent Prostate Cancer. Integrative Cancer Therapies. 1534735418803755. PMID 30289005 DOI: 10.1177/1534735418803755  0.43
2018 Greene LI, Bruno TC, Christenson JL, D'Alessandro A, Culp-Hill R, Torkko K, Borges VF, Slansky JE, Richer JK. A Role for Tryptophan-2,3-dioxygenase in CD8 T Cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma. Molecular Cancer Research : McR. PMID 30143553 DOI: 10.1158/1541-7786.Mcr-18-0362  0.352
2017 Gordon MA, D'Amato NC, Gu H, Babbs B, Wulfkuhle JD, Petricoin EF, Gallagher I, Dong T, Torkko K, Liu B, Elias A, Richer JK. Synergy between androgen receptor antagonism and inhibition of mTOR and HER2 in breast cancer. Molecular Cancer Therapeutics. PMID 28468774 DOI: 10.1158/1535-7163.Mct-17-0111  0.347
2017 Miles FL, Goodman PJ, Tangen C, Torkko KC, Schenk JM, Song X, Pollak M, Thompson IM, Neuhouser ML. Interactions of the Insulin-Like Growth Factor Axis and Vitamin D in Prostate Cancer Risk in the Prostate Cancer Prevention Trial. Nutrients. 9. PMID 28417914 DOI: 10.3390/Nu9040378  0.442
2017 Deep G, Panigrahi G, Singh R, Torkko K, Bokhoven A. Abstract B11: Proteomic analysis of serum-derived exosomes: Identification of novel protein signature associated with African-American prostate cancer Cancer Epidemiology, Biomarkers & Prevention. 26. DOI: 10.1158/1538-7755.Disp16-B11  0.34
2016 D'Amato NC, Gordon MA, Babbs B, Spoelstra NS, Carson Butterfield KT, Torkko KC, Phan VT, Barton VN, Rogers TJ, Sartorius CA, Elias A, Gertz J, Jacobsen BM, Richer JK. Cooperative Dynamics of AR and ER Activity in Breast Cancer. Molecular Cancer Research : McR. PMID 27565181 DOI: 10.1158/1541-7786.Mcr-16-0167  0.344
2016 Gari HH, Gearheart CM, Fosmire S, De Gala GD, Fan Z, Torkko KC, Edgerton SM, Lucia MS, Ray R, Thor AD, Porter CC, Lambert JR. Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers. Oncotarget. PMID 26909599 DOI: 10.18632/Oncotarget.7462  0.336
2015 Torkko KC, Wilson RS, Smith EE, Kusek JW, van Bokhoven A, Lucia MS. Prostate Biopsy Markers of Inflammation are Associated with Risk of Clinical Progression of Benign Prostatic Hyperplasia: Findings from the MTOPS Study. The Journal of Urology. PMID 25828974 DOI: 10.1016/J.Juro.2015.03.103  0.392
2015 Overholser S, Nielsen M, Torkko K, Cwilka D, Weaver B, Shi X, Leach RJ, Hernandez J, Huang T, Thompson IM, Thompson IM. Active Surveillance is an Appropriate Management Strategy for a Proportion of Men Diagnosed with Prostate Cancer by Prostate Specific Antigen Testing. The Journal of Urology. PMID 25636657 DOI: 10.1016/J.Juro.2015.01.089  0.466
2015 Lambert JR, Whitson RJ, Iczkowski KA, La Rosa FG, Smith ML, Wilson RS, Smith EE, Torkko KC, Gari HH, Lucia MS. Reduced expression of GDF-15 is associated with atrophic inflammatory lesions of the prostate. The Prostate. 75: 255-65. PMID 25327758 DOI: 10.1002/Pros.22911  0.421
2015 Torkko KC, Till C, Goodman PJ, Tangen CM, Bokhoven Av, Lucia MS, Thompson IM, Peters U, Neuhouser ML. Abstract B18: Interactions between finasteride and vitamin D-related polymorphisms is associated with prostate cancer risk in African American men Cancer Epidemiology, Biomarkers & Prevention. 24. DOI: 10.1158/1538-7755.Disp14-B18  0.413
2014 Schenk JM, Till CA, Tangen CM, Goodman PJ, Song X, Torkko KC, Kristal AR, Peters U, Neuhouser ML. Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1484-93. PMID 25085836 DOI: 10.1158/1055-9965.Epi-13-1340  0.462
2014 Cochrane DR, Bernales S, Jacobsen BM, Cittelly DM, Howe EN, D'Amato NC, Spoelstra NS, Edgerton SM, Jean A, Guerrero J, Gómez F, Medicherla S, Alfaro IE, McCullagh E, Jedlicka P, ... Torkko KC, et al. Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide. Breast Cancer Research : Bcr. 16: R7. PMID 24451109 DOI: 10.1186/Bcr3599  0.358
2014 Iczkowski KA, Torkko KC, Wilson RS, Lucia MS, Bostwick DG. Prostatic atrophy: its spatial proximity to carcinoma and intraepithelial neoplasia based on annotation of digital slides. Human Pathology. 45: 54-8. PMID 24157066 DOI: 10.1016/J.Humpath.2013.07.041  0.444
2013 Werahera PN, Crawford ED, La Rosa FG, Torkko KC, Schulte B, Sullivan HT, van Bokhoven A, Lucia MS, Kim FJ. Anterior tumors of the prostate: diagnosis and significance. The Canadian Journal of Urology. 20: 6897-906. PMID 24128826  0.316
2013 D'Amato NC, Gu H, Cochrane DR, Bernales S, Jacobsen BM, Jedlicka P, Torkko KC, Edgerton SM, Thor AD, Elias AD, Protter AA, Richer JK. Abstract 4756: Elucidating the role of AR in breast cancer . Cancer Research. 73: 4756-4756. DOI: 10.1158/1538-7445.Am2013-4756  0.372
2012 Whitson RJ, Genova E, Torkko K, Rosa FGL, Kelly J, Wilson S, Lambert JR, Lucia MS. Abstract B60: Prostate-derived factor/macrophage inhibitory cytokine-1/nonsteroidal anti-inflammatory drug activated gene: A mediator of prostatic inflammation Cancer Research. 72. DOI: 10.1158/1538-7445.Prca2012-B60  0.423
2011 Iczkowski KA, Torkko KC, Kotnis GR, Wilson RS, Huang W, Wheeler TM, Abeyta AM, Lucia MS. Pseudolumen size and perimeter in prostate cancer: correlation with patient outcome. Prostate Cancer. 2011: 693853. PMID 22110997 DOI: 10.1155/2011/693853  0.374
2011 Iczkowski KA, Torkko KC, Kotnis GR, Wilson RS, Huang W, Wheeler TM, Abeyta AM, La Rosa FG, Cook S, Werahera PN, Lucia MS. Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome. American Journal of Clinical Pathology. 136: 98-107. PMID 21685037 DOI: 10.1309/Ajcpz7Wbu9Yxsjpe  0.376
2011 Singh M, Mugler K, Hailoo DW, Burke S, Nemesure B, Torkko K, Shroyer KR. Differential expression of transferrin receptor (TfR) in a spectrum of normal to malignant breast tissues: implications for in situ and invasive carcinoma. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 19: 417-23. PMID 21297444 DOI: 10.1097/Pai.0B013E318209716E  0.319
2011 Torkko K, Bokhoven Av, Maroni P, Lucia S, McCartney S, Sullivan H, Fulmer J, Shappell S, Crawford D. 1909 Urine Pca3 Testing For The Early Detection Of Prostate Cancer. Feasibility, Test Performance, And Age And Race Associations Compared To Serum Psa In A Multi-Ethnic Population Over Four Years The Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.2047  0.412
2011 Ercole B, Livi CB, Price DK, Torkko KC, Drake JM, Cantrill CH, Thompson IM, Leach RJ. 1442 Constitutional Genetic Variation Associated With Prostate Cancer Progression The Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.1355  0.437
2008 Naresh A, Thor AD, Edgerton SM, Torkko KC, Kumar R, Jones FE. The HER4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosis. Cancer Research. 68: 6387-95. PMID 18676864 DOI: 10.1158/0008-5472.Can-08-0538  0.323
2008 Singh M, Spoelstra NS, Jean A, Howe E, Torkko KC, Clark HR, Darling DS, Shroyer KR, Horwitz KB, Broaddus RR, Richer JK. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 21: 912-23. PMID 18487993 DOI: 10.1038/Modpathol.2008.82  0.384
2008 Torkko KC, van Bokhoven A, Mai P, Beuten J, Balic I, Byers TE, Hokanson JE, Norris JM, Barón AE, Lucia MS, Thompson IM, Leach RJ. VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic White and Hispanic White men. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 3223-9. PMID 18483391 DOI: 10.1158/1078-0432.Ccr-07-4894  0.57
2008 Awadallah NS, Shroyer KR, Langer DA, Torkko KC, Chen YK, Bentz JS, Papkoff J, Liu W, Nash SR, Shah RJ. Detection of B7-H4 and p53 in pancreatic cancer: potential role as a cytological diagnostic adjunct. Pancreas. 36: 200-6. PMID 18376314 DOI: 10.1097/Mpa.0B013E318150E4E0  0.323
2008 Iczkowski KA, Hossain D, Torkko KC, Qian J, Lucia MS, Wheeler TM, Rewcastle JC, Bostwick DG. Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer. Urology. 71: 1166-71. PMID 18279927 DOI: 10.1016/J.Urology.2007.10.013  0.442
2007 Mugler KC, Singh M, Tringler B, Torkko KC, Liu W, Papkoff J, Shroyer KR. B7-h4 expression in a range of breast pathology: correlation with tumor T-cell infiltration. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 15: 363-70. PMID 18091377 DOI: 10.1097/01.Pai.0000213159.79557.71  0.339
2007 Shook SJ, Beuten J, Torkko KC, Johnson-Pais TL, Troyer DA, Thompson IM, Leach RJ. Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African Americans. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5959-64. PMID 17908993 DOI: 10.1158/1078-0432.Ccr-07-0702  0.466
2007 Leslie KK, Walter SA, Torkko K, Stephens JK, Thompson C, Singh M. Effect of tamoxifen on endometrial histology, hormone receptors, and cervical cytology: a prospective study with follow-up. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 15: 284-93. PMID 17721273 DOI: 10.1097/01.Pai.0000213147.54901.12  0.31
2007 Miyatake T, Tringler B, Liu W, Liu SH, Papkoff J, Enomoto T, Torkko KC, Dehn DL, Swisher A, Shroyer KR. B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration. Gynecologic Oncology. 106: 119-27. PMID 17509674 DOI: 10.1016/J.Ygyno.2007.03.039  0.31
2006 Balmer NN, Richer JK, Spoelstra NS, Torkko KC, Lyle PL, Singh M. Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 19: 1593-605. PMID 16980945 DOI: 10.1038/Modpathol.3800696  0.332
2006 Hernández J, Balic I, Johnson-Pais TL, Higgins BA, Torkko KC, Thompson IM, Leach RJ. Association between an estrogen receptor alpha gene polymorphism and the risk of prostate cancer in black men. The Journal of Urology. 175: 523-7. PMID 16406987 DOI: 10.1016/S0022-5347(05)00240-5  0.43
2006 Tringler B, Liu W, Corral L, Torkko KC, Enomoto T, Davidson S, Lucia MS, Heinz DE, Papkoff J, Shroyer KR. B7-H4 overexpression in ovarian tumors. Gynecologic Oncology. 100: 44-52. PMID 16256178 DOI: 10.1016/J.Ygyno.2005.08.060  0.34
2006 Werahera PN, Bokhoven AV, Rosa FGL, Wilson S, O'Donnell C, Torkko KC, Genova EE, Sullivan HT, Dayton R, Kim FJ, Crawford ED, Lucia MS. 1440: Association of Stromal, Epithelial, Smooth Muscle, and Luminal Compositions to Nodule Size and Symptom Severity of Benign Prostatic Hyperplasia The Journal of Urology. 175: 465-465. DOI: 10.1016/S0022-5347(18)33644-9  0.351
2006 Torkko KC, Mai P, Leach RJ, Higgins BA, Van Bokhoven A, Byers TE, Hokanson JE, Norris JM, Barón AE, Thompson IM, Lucia MS. 487: Vitamin D Receptor Gene Haplotypes and Prostate Cancer in Hispanic and Non-Hispanic White Men: Results from a Case-Control Genetic Association Study Journal of Urology. 175: 158-158. DOI: 10.1016/S0022-5347(18)32743-5  0.411
2005 Crawford ED, Wilson SS, Torkko KC, Hirano D, Stewart JS, Brammell C, Wilson RS, Kawata N, Sullivan H, Lucia MS, Werahera PN. Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy. Bju International. 96: 999-1004. PMID 16225516 DOI: 10.1111/J.1464-410X.2005.05801.X  0.439
2005 Tringler B, Zhuo S, Pilkington G, Torkko KC, Singh M, Lucia MS, Heinz DE, Papkoff J, Shroyer KR. B7-h4 is highly expressed in ductal and lobular breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 1842-8. PMID 15756008 DOI: 10.1158/1078-0432.Ccr-04-1658  0.356
2004 Werahera PN, Miller GJ, Torkko K, Crawford ED, Stewart JS, Deantoni EP, Miller HL, Lucia MS. Biomorphometric analysis of human prostatic carcinoma by using three-dimensional computer models. Human Pathology. 35: 798-807. PMID 15257542 DOI: 10.1016/J.Humpath.2004.02.015  0.444
2004 Lucia MS, Torkko KC. Inflammation as a target for prostate cancer chemoprevention: pathological and laboratory rationale. The Journal of Urology. 171: S30-4; discussion S3. PMID 14713750 DOI: 10.1097/01.Ju.0000108142.53241.47  0.447
2003 Kawata N, Miller GJ, Crawford ED, Torkko KC, Stewart JS, Lucia MS, Miller HL, Hirano D, Werahera PN. Laterally directed biopsies detect more clinically threatening prostate cancer: computer simulated results. The Prostate. 57: 118-28. PMID 12949935 DOI: 10.1002/Pros.10285  0.439
2001 Miller GJ, Torkko KC. Natural history of prostate cancer - Epidemiologic considerations Epidemiologic Reviews. 23: 14-18. PMID 11588839 DOI: 10.1093/Oxfordjournals.Epirev.A000780  0.453
Show low-probability matches.